|
Apoptosis
|
0.000971/12
|
0.000781/13
|
|
Chemokine signaling pathway
|
0.003907/20
|
0.001615/19
|
|
ErbB signaling pathway
|
0.030382/10
|
0.014949/11
|
|
mTOR signaling pathway
|
0.022528/7
|
0.020496/9
|
|
Insulin signaling pathway
|
0.037667/13
|
0.028081/14
|
|
Prostate cancer
|
0.038960/10
|
0.023229/12
|
|
Glutathione metabolism
|
0.039118/5
|
0.016997/6
|
|
beta-Alanine metabolism
|
0.040715/4
|
0.025722/5
|
|
Acute myeloid leukemia
|
0.041365/9
|
0.030514/11
|
|
VEGF signaling pathway
|
0.042746/11
|
0.0451753/9
|
|
Chronic myeloid leukemia
|
0.043575/10
|
0.043688/10
|
|
Cell cycle
|
0.044920/7
|
0.040853/7
|
|
Valine, leucine and isoleucine degradation
|
0.046396/7
|
0.041547/8
|
|
Glycerolipid metabolism
|
0.046614/7
|
0.042819/7
|
|
Fatty acid metabolism
|
0.047829/6
|
0.039429/7
|
|
Amyotrophic lateral sclerosis (ALS)
|
0.048708/7
|
0.045332/5
|
|
T cell receptor signaling pathway
|
0.049384/11
|
0.048102/11
|
|
B cell receptor signaling pathway
|
0.049921/8
|
0.040102/9
|
|
Regulation of actin cytoskeleton
|
0.049938/19
|
0.039208/14
|
|
Endometrial cancer
|
0.069635/8
|
0.049471/9
|
|
Pathways in cancer
|
0.101147/20
|
0.047471/25
|
|
Adipocytokine signaling pathway
|
0.104896/5
|
0.049791/7
|
|
MAPK signaling pathway
|
0.106127/17
|
0.047937/17
|
|
Epithelial cell signaling in Helicobacter pylori
|
0.115779/5
|
0.049997/6
|
